STUDIES
The 2009 Drug Discovery study assesses recent and upcoming developments in Discovery, focusing on trends that promise to shape the most successful Discovery organizations. Topics range from exploring the best environments for nurturing innovation to the most critical technology pursuits. The objective is to provide heads of research in biopharma with insight based on reliable, quantitative analysis of the discovery research organization, including an assessment of structure, investment, key measures, and trends in the areas of technology and licensing.